Oppenheimer analyst Ian Zaffino spoke to Kyndryl Holdings (KD) management after a short report was published, alleging accounting irregularities, manipulation of reported adjusted EBITDA and free cash flow, unusually high capitalized costs, and the specter of higher incremental costs from IBM (IBM). Overall, the firm does not believe there is a “smoking gun.” Management also issued a statement indicating the short report contains claims that are inaccurate and deliberately misleading. Oppenheimer would use this weakness as a buying opportunity and sees the dislocation as a chance to add to positions. The firm reiterates and Outperform rating on the shares with a price target of $43.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KD:
- Kyndryl shares ‘overreacted’ to negative short report, says BofA
- JPMorgan says Kyndryl short report ‘doesn’t dent’ Overweight thesis
- Kyndryl Holdings: Strategic Position and Revenue Growth Justify Buy Rating Despite Concerns
- Market Overreaction to Kyndryl Holdings’ Negative Research: Buy Rating Justified by Tyler DuPont CFA
- Kyndryl says short seller report ‘inaccurate and deliberately misleading’